Key inflammation markers such as TNF‐α and NF‐κB and oxidative markers such as nitrotyrosine residues and NOX expression/activity were frequently reported to be increased in vessels or blood of OSA patients [29–33], while antioxidant defenses such as SOD were diminished [34, 35]. The gene discussed is NFKB1; the disease is obstructive sleep apnea syndrome.